Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06972251 · ClinicalTrials.gov registry record · NA

TARDIS - Photo Elicitation and Intervention

A NA study of Type 2 Diabetes and Diabetes Mellitus Type II, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT06972251 is a NA study of Type 2 Diabetes and Diabetes Mellitus Type II that has completed, run by VA Office of Research and Development. The registered enrollment target is 34 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06972251, a NA study of Type 2 Diabetes and Diabetes Mellitus Type II, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

Veterans with type 2 diabetes (T2D) may become overwhelmed with the self-management behaviors needed to maintain optimal health. Veterans may experience diabetes distress (DD), a concept distinct from depression, due the amount and frequency of these behaviors. Diabetes distress negatively influences the Veteran's engagement in self-management and subsequent glycosylated hemoglobin (HbA1c) levels. Previous interventions aimed at improving T2D self-management and reducing DD do not tailor T2D self-management information to a Veteran's DD, which may be one reason interventions are ineffective at reducing DD. The purpose of this study is to further understand DD by expanding on what the investigators have learned thus far in cognitive and semi-structured interviews with Veterans (see ClinicalTrials.gov identifier NCT04587336). In Aim 3a, the photo elicitation study, the Veteran would be provided with a camera and instructed to take approximately 20 photos over two weeks. The investigators would conduct two semi-structured interviews with the Veteran to discuss this experience. Visual-based qualitative methods will help us identify and more robustly describe DD in Veterans. In Aim 3b, the investigators will conduct a pilot study of a novel telemedicine intervention. The TARDIS intervention (Aim 3b) will build off data collected in Aim 3a and provide tailored coaching to Veterans with type 2 diabetes mellitus. The TARDIS intervention includes coaching, self-management information, and referrals to Veterans Health Administration (VHA) supportive services delivered via the telephone. TARDIS will augment current VHA care for patients with diabetes. All Veterans will continue to receive care from their primary clinicians during the study.

Interventions

  • BEHAVIORAL TARDIS Photo Elicitation
  • BEHAVIORAL TARDIS Intervention

Study Locations (1)

North Carolina

  • Durham VA Medical Center, Durham, NC - Durham

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2022-03-08
Est. Completion 2025-03-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT06972251

The ClinicalTrials.gov registry entry for NCT06972251 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which TARDIS Photo Elicitation is the first listed.

NCT06972251 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06972251 about?

NCT06972251 is a clinical study titled "TARDIS - Photo Elicitation and Intervention". Veterans with type 2 diabetes (T2D) may become overwhelmed with the self-management behaviors needed to maintain optimal health. Veterans may experience diabetes distress (DD), a concept distinct from depression, due the amount and frequency of these behaviors. Diabetes distress negatively influence...

What is the current status of trial NCT06972251?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-03-08. Estimated completion is 2025-03-31.

What conditions does trial NCT06972251 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Diabetes Mellitus Type II, Self-management, Diabetes Distress, Veteran.

What interventions are being tested in trial NCT06972251?

The interventions under investigation include: TARDIS Photo Elicitation (BEHAVIORAL), TARDIS Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06972251?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06972251 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.